Close
Select up to 3 companies
| Company |
Bactolife
|
|
|
|
|---|---|---|---|---|
| Short Description | Developer of binding proteins to reduce various digestive illnesses in humans and animals |
|
|
|
| Status | Private |
|
|
|
| Year Founded | 2017 |
|
|
|
| Industry Group | agriculture & food |
|
|
|
| Sector | food & beverage |
|
|
|
| TRL Range | 4-6 |
|
|
|
| Country | Denmark |
|
|
|
| Nbr Employees |
|
|
|
|
| Revenue Range |
|
|
|
|
|
Total Equity Capital Raised |
$32.92M |
|
|
|
|
Last Stage Capital Raised |
Series A
round of
$32.92M
2023 |
|
|
|
| Investors | Bill & Melinda Gates Foundation, Novo Holdings, ATHOS |
|
|
|
Investment Data Information
Investment data is not editable by profile owners.
Please contact research@cleantech.com to make changes.
Close
Hey there!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
Startups
Use i3 to gain visibility with corporations and investors looking to invest and partner with external technology companies.
Contact us
Use i3 to access market intelligence on companies, investors, market activity and innovation trends.
Are you involved with a startup or SME looking for strategic partners, investors, or customers? Create your free profile!
Contact us to discuss the full power of i3:
Close
Request Received!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Get in touch
Message
Traction
Similar companies
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Back to top